Beijing Scitop Bio-tech Co., Ltd.

SZSE:300858 Stock Report

Market Cap: CN¥4.7b

Beijing Scitop Bio-tech Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Xiaojun Liu

Chief executive officer

CN¥3.4m

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership4.4%
Management average tenure5.2yrs
Board average tenure3yrs

Recent management updates

Recent updates

Analysis Article • Jan 05

Investors Still Waiting For A Pull Back In Beijing Scitop Bio-tech Co., Ltd. (SZSE:300858)

When close to half the companies in China have price-to-earnings ratios (or "P/E's") below 32x, you may consider...
Analysis Article • Nov 29

Beijing Scitop Bio-tech (SZSE:300858) Will Want To Turn Around Its Return Trends

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...
Analysis Article • Sep 27

Beijing Scitop Bio-tech Co., Ltd.'s (SZSE:300858) Earnings Haven't Escaped The Attention Of Investors

With a price-to-earnings (or "P/E") ratio of 41.7x Beijing Scitop Bio-tech Co., Ltd. ( SZSE:300858 ) may be sending...
Analysis Article • Aug 27

Weak Statutory Earnings May Not Tell The Whole Story For Beijing Scitop Bio-tech (SZSE:300858)

The subdued market reaction suggests that Beijing Scitop Bio-tech Co., Ltd.'s ( SZSE:300858 ) recent earnings didn't...
Analysis Article • Jun 29

Beijing Scitop Bio-tech (SZSE:300858) Will Pay A Smaller Dividend Than Last Year

Beijing Scitop Bio-tech Co., Ltd. ( SZSE:300858 ) is reducing its dividend from last year's comparable payment to...
Analysis Article • Apr 18

Investor Optimism Abounds Beijing Scitop Bio-tech Co., Ltd. (SZSE:300858) But Growth Is Lacking

When close to half the companies in China have price-to-earnings ratios (or "P/E's") below 29x, you may consider...
Analysis Article • Mar 22

Beijing Scitop Bio-tech (SZSE:300858) Is Reinvesting At Lower Rates Of Return

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...

CEO

Xiaojun Liu (44 yo)

no data
Tenure
CN¥3,378,700
Compensation

Mr. Xiaojun Liu serves as Director and General Manager at Beijing Scitop Bio-tech Co., Ltd.

Leadership Team

NamePositionTenureCompensationOwnership
Xiaojun Liu
GM & Directorno dataCN¥3.38m4.37%
CN¥ 203.3m
Ziying Yu
Accounting Supervisorno dataCN¥984.00kno data
Xiangqian Qiao
Deputy GM & Directorno dataCN¥555.30k3.51%
CN¥ 163.4m
Weichen Bao
Deputy General Manager3yrsCN¥796.70kno data
Lingyu Zhang
Board Secretary & Deputy GM5.6yrsCN¥817.40kno data
Jianjun Zhang
Deputy General Manager4.8yrsCN¥1.03mno data
Qimuge Sudu
Deputy General Manager5.6yrsCN¥589.20kno data
5.2yrs
Average Tenure
42yo
Average Age

Experienced Management: 300858's management team is seasoned and experienced (5.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Xiaojun Liu
GM & Directorno dataCN¥3.38m4.37%
CN¥ 203.3m
Xiangqian Qiao
Deputy GM & Directorno dataCN¥555.30k3.51%
CN¥ 163.4m
Tiansong Sun
Chairman of the Boardno dataCN¥1.99m19.94%
CN¥ 927.8m
Jie Chen
Chairman of the Supervisory Boardno datano datano data
Huiyu Liu
Independent Director4.9yrsCN¥100.00kno data
Xiao Guo
Employee Supervisorno datano datano data
Jihong Song
Employee Supervisorno datano datano data
Fei Lu
Independent Director3yrsCN¥100.00kno data
Fang Fang
Independent Director3yrsCN¥100.00kno data
3.0yrs
Average Tenure
44yo
Average Age

Experienced Board: 300858's board of directors are considered experienced (3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/17 00:34
End of Day Share Price 2026/05/15 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Beijing Scitop Bio-tech Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wendan WangChina International Capital Corporation Limited